Predictive biomarkers for kidney cancer
At the Society of Urologic Oncology (SUO) conference in Washington, [...]
Stereotactic radiation for the treatment of kidney cancer
This paper reviews the use of stereotactic body radiotherapy (SBRT) [...]
Root of childhood kidney cancer
Scientists at the Wellcome Sanger Institute in Cambridge have discovered [...]
Partial nephrectomy for kidney cancer
At the recent Society of Urologic Oncology (SUO) conference in [...]
Cytoreductive nephrectomy offers survival benefit in metastatic kidney cancer
The results of a trial looking at immunotherapy treatment with [...]
IKCS 2019: Immune related adverse events
Dr Mehmet Asim Bilen of Emory University School of Medicine [...]
Alternative schedule ipilimumab plus nivolumab for first-line treatment of advanced kidney cancer
The combination of nivolumab with ipilimumab has been proven to [...]
Effectiveness of targeted therapy after immunotherapy in metastatic kidney cancer patients
In this retrospective international study, the effectiveness of targeted therapy [...]
New first-line immunotherapy plus TKI combinations for metastatic kidney cancer
Approval of axitinib plus pembrolizumab and axitinib plus avelumab in [...]
IKCS 2019: Management of small renal masses
In this video interview, Dr Eric Singer from Rutgers Cancer [...]
